• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction.

作者信息

Li Ming, Xu Li

机构信息

Department of Traditional Chinese Medicine, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, 252000, PR China.

The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, PR China.

出版信息

Cardiovasc Drugs Ther. 2024 Dec;38(6):1187-1188. doi: 10.1007/s10557-024-07607-8. Epub 2024 Jul 15.

DOI:10.1007/s10557-024-07607-8
PMID:39008144
Abstract
摘要

相似文献

1
Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction.丹参酮IIA通过PGK1/PDHK1途径影响心肌梗死修复过程中的巨噬细胞重编程。
Cardiovasc Drugs Ther. 2024 Dec;38(6):1187-1188. doi: 10.1007/s10557-024-07607-8. Epub 2024 Jul 15.
2
Intervention of Tanshinone IIA on the PGK1-PDHK1 Pathway to Reprogram Macrophage Phenotype After Myocardial Infarction.丹参酮IIA对心肌梗死后PGK1-PDHK1通路重编程巨噬细胞表型的干预作用
Cardiovasc Drugs Ther. 2024 Dec;38(6):1359-1373. doi: 10.1007/s10557-023-07520-6. Epub 2023 Nov 22.
3
Tanshinone IIA Ameliorates Myocardial Ischemia-Reperfusion Injury via Activating HDAC1-Repressed Nrf2-xCT/Gpx4/HO-1 Axis.丹参酮IIA通过激活HDAC1抑制的Nrf2-xCT/Gpx4/HO-1轴改善心肌缺血再灌注损伤。
Chem Biol Drug Des. 2025 Apr;105(4):e70095. doi: 10.1111/cbdd.70095.
4
Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction.丹参酮IIA通过急性心肌梗死后的TLR4/NF-κB p65通路抑制心肌细胞焦亡。
Front Cell Dev Biol. 2023 Sep 12;11:1252942. doi: 10.3389/fcell.2023.1252942. eCollection 2023.
5
Efficacy of tanshinone IIA in rat models with myocardial ischemia-reperfusion injury: a systematic mini-review and meta-analysis.丹参酮 IIA 对心肌缺血再灌注损伤大鼠模型的疗效：系统迷你综述和荟萃分析。
PeerJ. 2024 Aug 16;12:e17885. doi: 10.7717/peerj.17885. eCollection 2024.
6
Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.丹参酮 IIA 和葛根素联合对心肌缺血小鼠心功能和炎症反应的影响。
J Mol Cell Cardiol. 2019 Dec;137:59-70. doi: 10.1016/j.yjmcc.2019.09.012. Epub 2019 Oct 17.
7
Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.PGK1 启动子低甲基化与 PGK1 介导的 PDHK1 磷酸化与癌症分期和预后的关联：TCGA 泛癌症分析。
Cancer Commun (Lond). 2019 Oct 2;39(1):54. doi: 10.1186/s40880-019-0401-9.
8
Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway.丹参酮IIA药物后处理通过激活磷脂酰肌醇3-激酶途径减轻大鼠心肌缺血再灌注损伤。
Exp Ther Med. 2014 Sep;8(3):973-977. doi: 10.3892/etm.2014.1820. Epub 2014 Jul 2.
9
Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats with myocardial infarction.丹参酮 IIA 通过 TLR4/MyD88/NF-κB 信号通路预防心肌梗死后大鼠的左心室重构。
J Cell Mol Med. 2018 Jun;22(6):3058-3072. doi: 10.1111/jcmm.13557. Epub 2018 Mar 10.
10
Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway.纳米颗粒介导的丹参酮 IIA 递送减少了小鼠心肌梗死模型中的心脏不良重构：NF-κB 通路的作用。
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S707-S716. doi: 10.1080/21691401.2018.1508028. Epub 2018 Oct 4.

引用本文的文献

1
Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms.丹参酮IIA抗呼吸系统疾病的研究进展：治疗靶点及潜在机制
Front Pharmacol. 2025 Feb 24;16:1505672. doi: 10.3389/fphar.2025.1505672. eCollection 2025.

本文引用的文献

1
TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53.TREM2 巨噬细胞通过 SLC25A53 重编程代谢促进心肌梗死后的心脏修复。
Cell Death Differ. 2024 Feb;31(2):239-253. doi: 10.1038/s41418-023-01252-8. Epub 2024 Jan 5.
2
Tanshinone‑IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes.丹参酮 IIA 通过减少心肌细胞中线粒体凋亡信号通路抑制心肌梗死。
Int J Mol Med. 2021 Aug;48(2). doi: 10.3892/ijmm.2021.4991. Epub 2021 Jul 2.
3
Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats.
丹参酮 IIA 通过抑制心肌梗死后大鼠的氧化应激减轻心力衰竭。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12043. Epub 2021 Mar 31.
4
Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway.丹参酮 IIA 通过 AMPKs/mTOR 依赖的自噬途径保护心肌梗死后的心衰。
Biomed Pharmacother. 2019 Apr;112:108599. doi: 10.1016/j.biopha.2019.108599. Epub 2019 Feb 21.